The impact of ovarian cancer heterogeneity and microenvironment on organoid based drug sensitivity assessment

2020/37/B/NZ5/01984

Keywords

Descriptors

  • NZ5_007: Leczenie chorób człowieka
  • NZ5_005: Diagnostyka chorób człowieka

Panel

NZ5 – Human and animal noninfectious diseases: etiology, mechanisms, diagnosis and treatment of diseases, poisonings and injuries (without neurological diseases)

Host institution

Uniwersytet Medyczny w Lublinie, Wydział Lekarski

Voivodeship: lubelskie

Other projects carried out by the institution »

Principal investigator (from the host institution)

prof. Jan Kotarski

Number of co-investigators in the project: 5

Call

OPUS 19 – announced on 2020-03-16

Amount awarded
1 951 517 PLN
Project start date
2021-03-01
Project end date
2025-02-28
Project duration
48 months (the same as in the proposal)
Project status
Project completed

Project description

Download the project description in a pdf file

Note — project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.

Information in the final report

Publication in academic press/journals (2)

  1. Integration of local and systemic immunity in ovarian cancer: Implications for immunotherapy

    Authors:
    Alicja Rajtak, Marta Ostrowska-Leśko, Klaudia Żak, Rafał Tarkowski, Jan Kotarski, Karolina Okła
    Academic press:
    Frontiers in Immunology (year: 2022, volume: 13, pages: nie dotyczy), Publisher: Frontiers
    Status:
    Published
    DOI:
    10.3389/fimmu.2022.1018256 – link to the publication
  2. Clinical Relevance of Mortalin in Ovarian Cancer Patients

    Authors:
    Alicja Rajtak, Arkadiusz Czerwonka, Michael Pitter , Jan Kotarski, Karolina Okła
    Academic press:
    Cells (year: 2023, volume: 12 issue 5, pages: nie dotyczy), Publisher: MDPI
    Status:
    Published
    DOI:
    10.3390/cells12050701 – link to the publication

« New search

Graphic design and implementation: Jakub Piotrowski